This Is The Right Way To Apply Perfume So It Lasts All Day

Parfum/Extrait de Parfum: At 25 to 40% fragrance concentrate, these are deep, rich, and designed to last all day with just a dab. Eau de Parfum: The most popular strength for its staying power (around ...

KEYTRUDA® (pembrolizumab) Demonstrates Long-Term Survival Benefit in Certain Patients With Earlier or Advanced Stages of Non-Small Cell Lung Cancer (NSCLC)

KEYTRUDA is indicated for the treatment of patients with resectable (tumors ≥4 cm or node positive) NSCLC in combination with platinum-containing chemotherapy as neoadjuvant treatment, and then ...
Healio

FDA approves Epioxa for keratoconus

Epioxa is the first epithelium-on cross-linking procedure approved in the U.S. Glaukos plans for Epioxa to be commercially ...
Healio

FDA approves Yuflyma for adolescent hidradenitis suppurativa, pediatric uveitis

The FDA approved expanded indications of Yuflyma and its unbranded version to treat hidradenitis suppurativa in adolescents aged 12 years and older and uveitis in children aged 2 years and older, ...
Ophthalmology Times

Glaukos receives FDA approval for Epioxa topical therapy for keratoconus

Glaukos announced that the FDA has approved the new drug application for its topical drug therapy (Epioxa HD/Epioxa) for keratoconus. 1,2 This approval makes it the first FDA-approved corneal ...
Dermatology Advisor

Extended Dupilumab Dosing as Effective as Standard Dosing Regimens for AD

Extended dosing of dupilumab in patients with AD has similar efficacy as standard dosing, with no significant affect seen on ocular adverse events.
Ophthalmology Advisor

Foselutoclax Delivers Durable Vision Benefits in Diabetic Macular Edema

Presenters at the AAO discussed phase 2 clinical trial results evaluating the safety and efficacy of foselutoclax (UBX1325) compared with aflibercept in diabetic macular edema.